Computational psychiatry approach to stigma subtyping in patients with mental disorders: explicit and implicit internalized stigma.

Background: Psychiatric stigma has potentially controversial effects on patients health-related behaviors. It appears that both stigmatization and motivation in psychiatric patients are heterogeneous and multi-dimensional, and that the relationship between stigma and treatment motivation may be more complex than previously believed.

Aim: To determine psychiatric stigma subtypes as they relate to treatment motivation among inpatients with various mental disorders.

[Antipsychotic selection strategies: the need for a holistic approach].

Objective: To describe the connections between strategies for antipsychotic prescribing and clinical, socio-psychological factors of treatment adherence in patients with psychotic disorders.

Material And Methods: The study included 83 inpatients with schizophrenic spectrum disorders (F2x) - 67%, affective disorders (F3x) - 15%, neurotic and personality (F4x + F6x) - 9%, organic diseases of the central nervous system (F0x) - 9%. We used a visual analog scale for patients' subjective severity of their condition, locus control test, Internalized stigma of mental disorder scale (ISMI), Treatment motivation assessment questionnaire (TMAQ), and Medication Compliance Scale (MCS), which also includes BPRS, SANS, GAF scales.

Revisiting Drug Compliance: The Need for a Holistic Approach in the Treatment of Severe Mental Disorders.

Introduction: The limited practice of depot antipsychotics and psychoeducation use, recommended for overcoming the noncompliance of patients with severe mental disorders, is linked to a high incidence of treatment violation. Therefore, the development of personalized mental healthcare approaches is a crucial healthcare task.

Aim: To describe and differentiate the role of clinical, social and psychological factors that lead to different level of treatment engagement of psychiatric inpatients.

[A role of motivation for treatment in the structure of compliance in psychopharmacologically treated patients].

Objective: To reveal an impact of specific motivation structures on the compliance in psychiatric inpatients.

Material And Methods: The Treatment Motivation Questionnaire and the Medication Compliance Scale have been administered to 104 patients, including 67 patients with schizophrenia and schizophrenia-spectrum disorders, 15 with affective disorders, 13 with personality and neurotic disorders and 9 with organic disorders, of the department of integrative pharmaco- and psychotherapy.

Results: A motivational mechanism based on the subjective suffering from disease plays a key role in the formation of overall score of compliance.

Evidence of the cross-cultural stability of the factor structure of the SKT short test for assessing deficits of memory and attention.

Many of the psychometric instruments employed in dementia research are adapted versions of tests developed in countries different from those in which they are applied. The validity of these instruments has been established in their countries of origin; however, there is little information available regarding their validity when transferred to other cultures. The SKT, a short cognitive performance test for the assessment of memory and attention deficits developed and validated in Germany, was administered in research centers in Chile, Greece, Russia, and England.